BlockMedx is a blockchain healthcare infrastructure project focusing on prescription drug fraud, abuse, and non-adherence. BlockMedx is building a next-generation smart e-prescribing and analytics ecosystem that can be used anywhere in the world to send and receive electronic prescriptions, predict patient risk behaviors, and automate micropayment incentives using the token economy to incentivize healthy behavior.
BlockMedx is the world’s first completely secure, HIPAA-compliant, end-to-end solution for transmitting DEA Controlled Drug prescriptions such as prescription opioid pain relievers and others, from physicians to pharmacies using the Ethereum blockchain. We are offering an EPCS compliant software platform integrated with a drug monitoring program using advanced analytics to detect fraud and abuse and predict patient addiction risk. The application also allows for low-cost medical e-consults anywhere in the world.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Gauthier Bros Rated on Dec 24, 2018 Modified on Dec 24, 2018
1
1
1
22%
One of my first reviews on ICOBench to test the review process.
I choose the worst rated ICOs from the directory
With no surprise this project seems dead!
e can't rate 0, it's why my rate is 1/1/1
One good point : It give me the opportunity to do a review!
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
The idea of BlockMedx is born;
Start of conceptual work.
2
Q2 2017
Development of basic prototype;
Outreach to relevant stakeholders and discussion of proposed solution.
3
Q1 2018
Completion of MVP;
BlockMedx network goes live.
4
Q3 2018
Private sale;
MassChallenge Accelerator start.
5
Q4 2018
Public token sale;
Intensive outreach to strategic partners.
6
Q1 2019
Version 2 Application Upgrades as Protocol Advances.
7
Q1 2019
Intensify implementations with healthcare systems;
Rapid scalling into additional states with the highest opioid death rates;
EMR and Telehealth platform API Access and Integration.
8
Q2 2019
Key partnership with addiction treatment organizations for patient education, communication, and early intervention;
Expansion pf network into all prescription drugs with incorporation of communication, education, and early intervention incentive structures.
9
Q3 2019
Partnerships with payors and healthcare systems to allow discounted payments through patient portal and introduce new value based incentive structure that promotes early prevention rather than treatment.
10
Q4 2019
ML/AI implementations to automate detection of fraud and abuse in the healthcare system - important to prevent patients from being lost in the system after it is too late;
Integration with Pharmaceutical supply chain to prevent counterfeit drugs from entering the market.
